The Pharma Pricing & Market Access Summit 2025 is a premier industry event scheduled for November 13–14, 2025, in Madrid. It brings together global leaders in pharmaceutical pricing, market access, health economics, and reimbursement to tackle the latest challenges and opportunities in the sector. With 100+ expert speakers and attendees, the summit offers a platform for knowledge sharing, collaboration, and networking across the pharmaceutical, biotech, payer, and regulatory communities.

Amid growing pressure for affordability and value-driven care, the summit serves as a platform to discuss sustainable pricing models, patient-centric access strategies, and digital innovation in reimbursement processes.

Key topics

• • EU HTA Implementation: Impacts of the EU Health Technology Assessment regulation on market access strategies.

• • Innovative Pricing Models: Including outcomes-based pricing, subscription models, and managed entry agreements.

• • Global Access and Equity: Strategies to improve access in emerging markets and underserved regions.

• • Real-World Evidence (RWE) & Data Use: Enhancing pricing decisions and HTA submissions with real-world data.

• • Digital Health & Innovation: The role of digital tools in market access and patient outcomes.

• • Rare Diseases & Orphan Drugs: Navigating the unique pricing and access challenges in rare disease treatments.

• • Health Economics & Value Frameworks: Evolving value assessments and cost-effectiveness evaluations.

• • Patient-Centered Access: Incorporating patient perspectives in access planning and value demonstration.
    
    
  • Policy Trends & Regulation: Navigating international pricing reforms and evolving policy landscapes.